MedTrace Logo

N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary Hypertension

NCT00443859 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2016-07-11

No results posted yet for this study

Summary

Babies who are suspected of having persistent pulmonary hypertension (PPHN) will be included in this study. PPHN is a condition in which the blood is restricted from flowing to the lungs in a normal way making it hard for babies to breath and placing strain on the heart. This study will observe whether certain hormones that measure stress (N-terminal pro-brain natriuretic peptide) can help determine how well a baby will do when they have PPHN.

Conditions

  • Persistent Pulmonary Hypertension of Newborn

Sponsors & Collaborators

  • Thomas Jefferson University

    collaborator OTHER

  • Christiana Care Health Services

    lead OTHER

Principal Investigators

  • Euming Chong, MD · Christiana Hospital / Thomas Jefferson University Hospital

  • Constance Andrejko, DO · Christiana Hospital / Thomas Jefferson University Hospital

Eligibility

Max Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00443859 on ClinicalTrials.gov